Cerecor raises $26M in a downsized IPO to fund its depression pipeline – FierceBiotech

Baltimore biotech Cerecor raised $26 million in an IPO to bankroll its work on treatments for depression, issuing warrants to bring in the cash it needs.

Source: www.fiercebiotech.com



Comments are closed.